MarketCap
Facebook
X
Telegram
MGP Ingredients Financial Ratios 2025-2011 | MGPI
Brief overview of MGP Ingredients's multiples and efficiency
The review covers five available annual periods spanning 2020 to 2024.
Market valuation is represented by P/E 20.58x (median 19.63x), EV/EBITDA 14.55x (median 14.86x), P/S 0.8x (median 2.07x). The combined multiple level is about 61.3% below the company's historical norm, suggesting more cautious expectations.
The inverse P/E implies an earnings yield of 4.9%. This is not a dividend yield, but current earnings relative to market price.
Current measures of operating quality are ROE -15%, ROA -8.7%, ROCE -13.2%. Negative returns point to losses or poor capital efficiency. Valuation multiples are less informative in this setting.
PEG is 0.15x. Price is low relative to embedded growth, though the ratio depends heavily on forecast quality.
The cash conversion cycle increased 16.9 days to 24.6 days, weakening working-capital efficiency.
Conclusion
MGP Ingredients's discount may reflect genuine profitability issues rather than market inefficiency alone.
Annual Financial Ratios MGP Ingredients
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-4.0 | 20.6 | 16.1 | 21.2 | 19.3 | 19.6 | 14.8 | 32.1 | 32.0 | 22.4 | 14.6 | 11.6 | -19.2 | 39.6 | -100.3 |
P/S |
0.8 | 1.0 | 2.1 | 3.0 | 2.8 | 2.0 | 1.6 | 3.2 | 3.9 | 2.2 | 1.2 | 0.9 | 0.3 | 0.2 | 0.5 |
EPS |
-5.0 | 1.6 | 4.8 | 4.9 | 4.4 | 2.4 | 2.3 | 2.2 | 2.4 | 1.8 | 1.5 | 1.3 | -0.3 | 0.1 | -0.1 |
EV (Enterprise Value) |
930 M | 1.26 B | 2.26 B | 2.69 B | 2.14 B | 874 M | 663 M | 1.27 B | 1.41 B | 775 M | 461 M | 325 M | 161 M | 141 M | 190 M |
EBITDA per Share |
-3.3 | 4.38 | 7.74 | 7.75 | 7.02 | 3.97 | 3.46 | 3.65 | 3.24 | 3.2 | 2.64 | 1.19 | 0.399 | 0.627 | 0.582 |
EV/EBITDA |
14.5 | 14.9 | 10.4 | 19.9 | 25.1 | 13.7 | 9.2 | 13.5 | 16.8 | 9.1 | 14.1 | ||||
PEG |
0.15 | 1.76 | 0.83 | 0.97 | 0.96 | 2.2 | 3.22 | -2.9 | 0.94 | 0.97 | 1.21 | 0.02 | 0.05 | -0.46 | 0.88 |
P/B |
0.6 | 0.9 | 2.0 | 3.1 | 2.7 | 3.0 | 2.5 | 5.9 | 7.9 | 4.8 | 3.3 | 2.6 | 1.2 | 0.7 | 1.8 |
P/CF |
3.5 | 7.0 | 20.7 | 26.2 | 20.0 | 14.9 | 192.2 | 491.7 | 107.9 | 387.5 | -32.3 | 31.0 | 8.5 | -4.5 | -13.7 |
ROE % |
-15.01 | 4.16 | 12.66 | 14.68 | 14.17 | 15.37 | 16.79 | 18.51 | 24.79 | 21.32 | 22.55 | 22.68 | -6.04 | 1.87 | -1.75 |
ROA % |
-8.72 | 2.47 | 7.72 | 9.45 | 8.77 | 11.01 | 12.03 | 13.42 | 17.40 | 13.84 | 13.48 | 14.74 | -3.26 | 1.00 | -0.98 |
ROCE % |
-13.17 | 8.92 | 17.50 | 19.98 | 19.61 | 20.66 | 16.68 | 20.86 | 21.59 | 22.29 | 20.97 | 6.41 | -4.44 | -0.71 | 0.91 |
Current Ratio |
2.4 | 2.5 | 2.6 | 2.8 | 2.6 | 3.5 | 4.7 | 4.1 | 3.2 | 3.0 | 2.4 | 2.7 | 2.1 | 2.6 | 1.6 |
DSO |
90.0 | 75.9 | 55.3 | 47.1 | 43.5 | 45.2 | 42.2 | 38.3 | 38.2 | 33.0 | 34.2 | 38.5 | 31.9 | 38.8 | 41.8 |
DIO |
- | - | - | - | - | - | 174.6 | 135.7 | 125.3 | 113.8 | 79.6 | 44.1 | 42.2 | 43.1 | 24.0 |
DPO |
65.5 | 61.2 | 48.1 | 41.4 | 35.8 | 36.8 | 37.6 | 31.7 | 40.4 | 29.3 | 28.4 | 20.6 | 27.9 | 22.3 | 39.3 |
Operating Cycle |
90.0 | 75.9 | 55.3 | 47.1 | 43.5 | 45.2 | 216.8 | 174.1 | 163.4 | 146.8 | 113.8 | 82.6 | 74.1 | 81.9 | 65.8 |
Cash Conversion Cycle |
24.6 | 14.7 | 7.3 | 5.6 | 7.7 | 8.4 | 179.2 | 142.4 | 123.0 | 117.4 | 85.4 | 62.0 | 46.2 | 59.7 | 26.5 |
All numbers in USD currency
Quarterly Financial Ratios MGP Ingredients
| 2026-Q1 | 2025-Q4 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-6.3 | - | 0.67 | -0.14 | - | 1.07 | 1.43 | 0.92 | - | 0.59 | 1.44 | 1.4 | - | 1.07 | 1.15 | 1.69 | 1.44 | 1.08 | 0.91 | 0.9 | 0.69 | 0.61 | 0.5 | 0.57 | 0.76 | 0.48 | 0.46 | 0.57 | 0.69 | 0.52 | 0.44 | 0.52 | 0.74 | 0.82 | 0.37 | 0.5 | 0.48 | 0.55 | 0.37 | 0.41 | 0.38 | 0.38 | 0.44 | 0.28 | 0.42 | 0.34 | 0.28 | 0.26 | -0.02 | -0.37 | 0.02 | 0.08 | 0.01 | 0.02 | -0.05 | 0.1 | - | -0.33 | -0.61 | 0.04 |
EBITDA per Share |
-7.8 | - | 1.22 | 0.24 | - | 1.73 | 2.2 | 1.54 | - | 1.16 | 2.24 | 2.12 | - | 1.78 | 1.85 | 2.53 | 2.06 | 1.73 | 1.5 | 1.41 | 0.92 | 1 | 0.86 | 0.99 | 0.95 | 0.85 | 0.8 | 0.67 | 0.99 | 0.87 | 0.83 | 0.79 | 0.63 | 0.8 | 0.8 | 0.85 | 0.64 | 0.85 | 0.71 | 0.84 | 0.6 | 0.55 | 0.72 | 0.57 | 0.46 | 0.39 | 0.36 | 0.28 | -0.06 | -0.17 | 0.21 | 0.25 | 0.05 | 0.22 | 0.14 | 0.04 | - | -0.01 | -0.33 | 0.18 |
ROE % |
-20.13 | 3.96 | 6.58 | 8.46 | 8.59 | 10.21 | 9.21 | 9.59 | 9.60 | 12.89 | 14.56 | 14.22 | 12.43 | 17.34 | 17.93 | 17.67 | 17.71 | 17.23 | 17.30 | 17.16 | 15.37 | 16.54 | 16.14 | 16.33 | 16.79 | 17.06 | 17.97 | 18.28 | 18.51 | 20.13 | 24.04 | 24.08 | 24.79 | 22.96 | 21.10 | 21.63 | 21.32 | 21.23 | 20.54 | 23.01 | 22.55 | 24.22 | 24.35 | 22.46 | 22.68 | 15.00 | 1.28 | -3.27 | -6.04 | -5.39 | 2.84 | 1.52 | 1.87 | -4.86 | -11.87 | -23.04 | -17.84 | -6.52 | -12.15 | 0.83 |
ROA % |
-11.21 | 2.48 | 4.14 | 5.34 | 5.38 | 6.35 | 5.66 | 5.72 | 5.89 | 8.00 | 9.13 | 10.30 | 9.04 | 12.08 | 8.86 | 10.83 | 11.41 | 11.55 | 12.03 | 12.37 | 11.01 | 11.85 | 11.56 | 11.70 | 12.03 | 12.27 | 12.96 | 13.22 | 13.42 | 14.42 | 17.06 | 17.00 | 17.40 | 15.82 | 14.17 | 14.32 | 13.84 | 13.50 | 12.75 | 14.00 | 13.48 | 14.87 | 15.26 | 14.38 | 14.75 | 9.79 | 1.74 | -1.25 | -3.26 | -2.91 | 1.53 | 0.82 | 1.00 | -2.37 | -5.88 | -11.43 | -8.91 | -3.26 | -6.06 | 0.41 |
ROCE % |
-25.06 | 5.88 | 9.45 | 11.89 | 11.76 | 14.19 | 13.05 | 13.66 | 13.25 | 17.93 | 20.18 | 19.73 | 17.07 | 24.10 | 24.77 | 24.41 | 24.40 | 23.29 | 23.14 | 22.80 | 20.66 | 21.77 | 21.60 | 21.98 | 20.45 | 21.66 | 22.60 | 23.42 | 24.89 | 22.89 | 23.13 | 23.84 | 25.43 | 26.43 | 28.11 | 28.11 | 28.69 | 30.12 | 27.72 | 29.66 | 28.28 | 27.45 | 25.45 | 20.21 | 15.92 | 6.79 | -3.99 | -6.30 | -6.37 | -3.95 | 4.34 | 3.08 | -1.09 | -5.26 | -9.32 | -18.27 | -11.66 | -3.05 | -9.59 | 0.98 |
Current Ratio |
2.3 | 2.4 | 2.5 | 2.5 | 2.5 | 2.7 | 2.6 | 2.6 | 2.6 | 2.5 | 2.4 | 2.9 | 2.8 | 2.8 | - | 2.7 | 2.6 | 2.5 | 2.4 | 3.7 | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 | 3.6 | 3.6 | 3.6 | 3.6 | 3.4 | 3.4 | 3.4 | 3.4 | 2.9 | 2.9 | 2.9 | 2.9 | 2.5 | 2.5 | 2.5 | 2.5 | 2.9 | 2.9 | 2.9 | 2.9 | 2.2 | 2.2 | 2.2 | 2.2 | 2.1 | 2.1 | 2.1 | 2.1 | 2.0 | 2.0 | 2.0 | 2.0 |
DSO |
86.9 | - | 70.6 | 96.1 | - | 81.8 | 69.8 | 74.2 | - | 59.1 | 60.3 | 54.0 | - | 24.4 | 23.9 | 45.5 | 50.5 | 44.2 | 38.1 | 52.3 | 51.5 | 50.5 | 56.2 | 45.1 | 40.2 | 41.3 | 43.1 | 42.3 | 38.6 | 42.6 | 40.1 | 37.9 | 35.5 | 36.3 | 36.5 | 31.6 | 29.3 | 29.8 | 29.6 | 33.7 | 30420.0 | 34.8 | 32.8 | 35.9 | 1046.1 | 1839.2 | 1279.0 | 827.6 | 3349.2 | -27897.4 | 35755.9 | -3058.4 | -6932.1 | -24795.4 | -22541.3 | 33.4 | - | 33.3 | -1105.0 | - |
DPO |
65.3 | - | 50.5 | 70.3 | - | 52.4 | 44.8 | 52.1 | - | 46.0 | 52.1 | 46.3 | - | 20.8 | 17.7 | 39.4 | 36.3 | 28.4 | 25.5 | 35.3 | 39.9 | 34.6 | 38.4 | 36.0 | 38.0 | 37.5 | 37.9 | 34.6 | 29.2 | 30.7 | 33.6 | 36.6 | 39.9 | 40.5 | 41.0 | 33.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
86.9 | - | 70.6 | 96.1 | - | 81.8 | 69.8 | 74.2 | - | 59.1 | 60.3 | 54.0 | - | 24.4 | 23.9 | 45.5 | 50.5 | 44.2 | 38.1 | 52.3 | 51.5 | 50.5 | 56.2 | 45.1 | 40.2 | 41.3 | 43.1 | 42.3 | 38.6 | 42.6 | 40.1 | 37.9 | 35.5 | 36.3 | 36.5 | 31.6 | 29.3 | 29.8 | 29.6 | 33.7 | 30420.0 | 34.8 | 32.8 | 35.9 | 1046.1 | 1839.2 | 1279.0 | 827.6 | 3349.2 | -27897.4 | 35755.9 | -3058.4 | -6932.1 | -24795.4 | -22541.3 | 33.4 | - | 33.3 | -1105.0 | - |
Cash Conversion Cycle |
21.6 | - | 20.1 | 25.8 | - | 29.4 | 25.0 | 22.0 | - | 13.1 | 8.1 | 7.7 | - | 3.6 | 6.2 | 6.1 | 14.2 | 15.8 | 12.7 | 17.0 | 11.6 | 15.9 | 17.7 | 9.1 | 2.2 | 3.9 | 5.2 | 7.8 | 9.4 | 11.9 | 6.5 | 1.3 | -4.4 | -4.2 | -4.4 | -2.1 | 29.3 | 29.8 | 29.6 | 33.7 | 30420.0 | 34.8 | 32.8 | 35.9 | 1046.1 | 1839.2 | 1279.0 | 827.6 | 3349.2 | -27897.4 | 35755.9 | -3058.4 | -6932.1 | -24795.4 | -22541.3 | 33.4 | - | 33.3 | -1105.0 | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company MGP Ingredients, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
USA
Russia
Canada
Brasil
China
Cayman-islands
